0001516513FALSE00015165132024-08-082024-08-08

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________________________________________________________________________________________________________
FORM 8-K
_________________________________________________________________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 8, 2024
_________________________________________________________________________________________________________________
Doximity, Inc.
(Exact Name of Registrant as Specified in Its Charter)
_________________________________________________________________________________________________________________
Delaware001-4050827-2485512
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(I.R.S. Employer Identification Number)
500 3rd St.
Suite 510
San Francisco, CA 94107
(Address of principal executive offices, including zip code)
(650) 549-4330
(Registrant's telephone number, including area code)
_______________________________________________________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A common stock, $0.001 par value per shareDOCSThe New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 2.02 – Results of Operations and Financial Condition
On August 8, 2024, Doximity, Inc. (“Doximity”) issued a press release announcing its financial results for its fiscal quarter ended June 30, 2024. A copy of the press release is attached as Exhibit 99.1 to this current report on Form 8-K and is incorporated by reference herein.
The information provided in this Item 2.02 of this Current Report on Form 8-K, and the Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01 – Financial Statements and Exhibits
(d) Exhibits
Exhibit NumberDescription
99.1
104Cover Page Interactive Data File (embedded within the inline XBRL document)


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 8, 2024
DOXIMITY, INC.
By:
/s/ Anna Bryson
Anna Bryson
Chief Financial Officer



Exhibit 99.1
Doximity Announces Fiscal 2025 First Quarter Financial Results
Total revenues of $126.7 million, up 17% year-over-year
Net income growth of 46% and adjusted EBITDA growth of 42% year-over-year

SAN FRANCISCO, Calif., August 8, 2024 -- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 first quarter ended June 30, 2024.
“We were pleased to deliver strong profits and record engagement last quarter, as we beat on both our top and bottom lines,” said Jeff Tangney, co-founder and CEO of Doximity. “Last quarter, a record 590,000 unique providers used our AI, telehealth, messaging, and scheduling workflow tools to save time and better serve their patients.”
Fiscal 2025 First Quarter Financial Highlights
All comparisons, unless otherwise noted, are to the three months ended June 30, 2023.
•Revenue: Revenue of $126.7 million, versus $108.5 million, an increase of 17% year-over-year.
•Net income and non-GAAP net income: Net income of $41.4 million, versus $28.4 million, representing a margin of 32.7%, versus 26.2%. Non-GAAP net income of $55.9 million, versus $40.6 million, representing a margin of 44.1%, versus 37.5%.
•Adjusted EBITDA: Adjusted EBITDA of $65.9 million, versus $46.6 million, an increase of 42% year-over-year, representing adjusted EBITDA margins of 52.0%, versus 42.9%.
•Diluted net income per share and non-GAAP diluted net income per share: Diluted net income per share was $0.21, versus $0.13, while non-GAAP diluted net income per share was $0.28, versus $0.19.
•Operating cash flow and free cash flow: Operating cash flow of $41.2 million, versus $57.2 million, a decrease of 28% year-over-year, and free cash flow of $39.5 million, versus $55.6 million, a decrease of 29% year-over-year.
Financial Outlook
Doximity is providing guidance for its fiscal second quarter ending September 30, 2024 as follows:
•Revenue between $126.5 million and $127.5 million.
•Adjusted EBITDA between $62.5 million and $63.5 million.
Doximity is providing guidance for its fiscal year ending March 31, 2025 as follows:
•Revenue between $514 million and $523 million.
•Adjusted EBITDA between $248.5 million and $257.5 million.
1

Conference Call Information
Doximity posted prepared remarks on its investor relations website at https://investors.doximity.com. Doximity will host a webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results. To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com. The archived webcast will be available on the Company’s Investor Relations page shortly after the call.
About Doximity
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.
Forward-Looking Statements
Statements we make in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including (i) the timing and scope of anticipated stock repurchases; (ii) the impact of uncertainty in the current economic environment and macroeconomic uncertainty; (iii) our ability to retain existing members or add new members to our platform and maintain or grow their engagement with our platform; (iv) our ability to attract new customers or retain existing customers; (v) the impact of our prioritization of our members’ interests; (vi) breaches in our security measures or unauthorized access to members’ data; (vii) our ability to maintain or manage our growth, and other risks and factors that are beyond our control including, without limitation, those set forth in the section entitled “Risk Factors”in our Annual Report on Form 10-K for the fiscal year ended March 31, 2024 and as may be updated in any subsequent Quarterly Reports on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this press release relate only to management’s beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Investor Relations Contact:
Perry Gold
ir@doximity.com
Media Contact:
Amanda Cox
pr@doximity.com




2

DOXIMITY, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
(unaudited)
June 30, 2024March 31, 2024
Assets
Current assets:
Cash and cash equivalents$111,442 $96,785 
Marketable securities639,046 666,115 
Accounts receivable, net 120,910 101,332 
Prepaid expenses and other current assets37,068 48,709 
Total current assets908,466 912,941 
Property and equipment, net12,869 12,318 
Deferred income tax assets44,742 45,068 
Operating lease right-of-use assets11,852 12,332 
Intangible assets, net26,256 27,317 
Goodwill67,940 67,940 
Other assets1,333 1,458 
Total assets$1,073,458 $1,079,374 
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$1,656 $2,253 
Accrued expenses and other current liabilities28,488 43,703 
Deferred revenue, current102,943 99,145 
Operating lease liabilities, current2,190 2,149 
Total current liabilities135,277 147,250 
Deferred revenue, non-current116 211 
Operating lease liabilities, non-current11,841 12,397 
Contingent earn-out consideration liability, non-current5,349 10,895 
Other liabilities, non-current7,295 7,224 
Total liabilities159,878 177,977 
Stockholders' Equity
Preferred stock— — 
Common stock186 187 
Additional paid-in capital841,470 823,885 
Accumulated other comprehensive loss(1,008)(2,664)
Retained earnings72,932 79,989 
Total stockholders’ equity
913,580 901,397 
Total liabilities and stockholders’ equity$1,073,458 $1,079,374 

3

DOXIMITY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
Three Months Ended June 30,
20242023
Revenue$126,676 $108,469 
Cost of revenue(1)
13,550 13,153 
Gross profit113,126 95,316 
Operating expenses(1):
Research and development22,574 21,931 
Sales and marketing35,244 34,455 
General and administrative9,255 9,247 
Total operating expenses67,073 65,633 
Income from operations46,053 29,683 
Other income, net7,116 4,839 
Income before income taxes53,169 34,522 
Provision for income taxes11,792 6,116 
Net income$41,377 $28,406 
Net income per share attributable to Class A and Class B common stockholders:
Basic$0.22 $0.15 
Diluted$0.21 $0.13 
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:
Basic185,610 194,521 
Diluted199,224 212,355 
(1) Costs and expenses include stock-based compensation expense as follows (in thousands):
Three Months Ended June 30,
20242023
Cost of revenue$2,894 $2,461 
Research and development4,684 3,256 
Sales and marketing6,586 5,995 
General and administrative2,926 2,289 
Total stock-based compensation expense$17,090 $14,001 
4

DOXIMITY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
Three Months Ended June 30,
20242023
Cash flows from operating activities
Net income$41,377 $28,406 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization2,562 2,604 
Stock-based compensation, net of amounts capitalized17,090 14,001 
Non-cash lease expense481 537 
Accretion of discount on marketable securities, net(2,360)(299)
Net loss on sale of marketable securities— 273 
Amortization of deferred contract costs2,726 2,667 
Change in fair value of contingent earn-out consideration liability
202 269 
Other(738)(421)
Changes in operating assets and liabilities:
Accounts receivable(19,372)14,032 
Prepaid expenses and other assets10,460 2,589 
Deferred contract costs(1,431)(1,210)
Accounts payable, accrued expenses and other liabilities(12,942)677 
Deferred revenue3,704 (6,922)
Operating lease liabilities(516)(3)
Net cash provided by operating activities41,243 57,200 
Cash flows from investing activities
Purchases of property and equipment— (70)
Internal-use software development costs(1,704)(1,494)
Purchases of marketable securities(170,413)(35,284)
Maturities of marketable securities202,058 116,649 
Sales of marketable securities— 37,525 
Net cash provided by investing activities29,941 117,326 
Cash flows from financing activities
Proceeds from issuance of common stock upon exercise of stock options
2,551 3,285 
Taxes paid related to net share settlement of equity awards(2,394)(1,964)
Repurchase of common stock(51,214)(21,755)
Payment of contingent consideration related to a business combination(5,470)(5,390)
Net cash used in financing activities(56,527)(25,824)
Net increase in cash and cash equivalents14,657 148,702 
Cash and cash equivalents, beginning of period96,785 158,027 
Cash and cash equivalents, end of period
$111,442 $306,729 
Supplemental disclosures of cash flow information
Cash paid for taxes, net of refunds
$12,907 $— 

5

Non-GAAP Financial Measures
To supplement our condensed consolidated financial statements, which are prepared and presented in accordance with accounting principles generally accepted in the United States (“GAAP”), the Company uses the following non-GAAP measures of financial performance:
•Non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP net income, non-GAAP net income margin, and non-GAAP basic and diluted net income per common share: We exclude the effect of stock-based compensation expense, amortization of acquired intangible assets, and change in fair value of contingent earn-out consideration liability from non-GAAP gross profit, non-GAAP gross margin and non-GAAP operating income. Non-GAAP net income and non-GAAP net income margin are further adjusted for estimated income tax on such adjustments. We calculate income taxes on the adjustments by applying an estimated annual effective tax rate to the adjustments. Non-GAAP basic and diluted net income per common share is non-GAAP net income attributable to common stockholders divided by the weighted average number of shares. For both basic and diluted non-GAAP net income per share, the weighted average shares we use in computing non-GAAP net income per share is equal to our GAAP weighted average shares. Non-GAAP gross margin represents non-GAAP gross profit as a percentage of revenue and non-GAAP net income margin represents non-GAAP net income as a percentage of revenue.
•Adjusted EBITDA and adjusted EBITDA margin: We define adjusted EBITDA as net income before interest, income taxes, depreciation, and amortization, and as further adjusted for stock-based compensation expense, change in fair value of contingent earn-out consideration liability, and other income, net. Net income margin represents net income as a percentage of revenue and adjusted EBITDA margin represents adjusted EBITDA as a percentage of revenue.
•Free cash flow: We calculate free cash flow as cash flow from operating activities less purchases of property and equipment and internal-use software development costs.
We use these non-GAAP financial measures internally for financial and operational decision-making purposes and as a means to evaluate period-to-period comparisons. Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. Our presentation of non-GAAP financial measures may not be comparable to similar measures used by other companies. We encourage investors to carefully consider our results under GAAP, as well as our supplemental non-GAAP information and the reconciliation between these presentations, to more fully understand our business. Please see the tables included at the end of this release for the reconciliation of GAAP to non-GAAP results.
Key Business Metrics
•Net revenue retention rate: Net revenue retention rate is calculated by taking the trailing 12-month (“TTM”) subscription-based revenue from our customers that had revenue in the prior TTM period and dividing that by the total subscription-based revenue for the prior TTM period. For the purposes of this calculation, subscription revenue excludes subscriptions for individuals and small practices and other non-recurring items. Our net revenue retention rate compares our subscription revenue from the same set of customers across comparable periods, and reflects customer renewals, expansion, contraction, and churn. Our net revenue retention rate is directly tied to our revenue growth rate and thus fluctuates as that growth rate fluctuates.
•Customers with trailing 12-month subscription revenue greater than $500,000: The number of customers with TTM subscription revenue greater than $500,000 is a key indicator of the scale of our business, and is calculated by counting the number of customers that contributed more than $500,000 in subscription revenue in the TTM period. Our customer count is subject to adjustments for acquisitions, consolidations, spin-offs, and other market activity, and we present our total customer count for historical periods reflecting these adjustments.
6

Reconciliation of GAAP to Non-GAAP Financial Measures
The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below:
Three Months Ended June 30,
20242023
(unaudited)
(in thousands, except percentages)
Net income$41,377 $28,406 
Adjusted to exclude the following:
Stock-based compensation17,090 14,001 
Depreciation and amortization2,562 2,604 
Provision for income taxes11,792 6,116 
Change in fair value of contingent earn-out consideration liability202 269 
Other income, net(7,116)(4,839)
Adjusted EBITDA$65,907 $46,557 
Revenue$126,676 $108,469 
Net income margin32.7 %26.2 %
Adjusted EBITDA margin52.0 %42.9 %

Three Months Ended June 30,
20242023
(unaudited)
(in thousands)
Net cash provided by operating activities$41,243 $57,200 
Purchases of property and equipment— (70)
Internal-use software development costs(1,704)(1,494)
Free cash flow$39,539 $55,636 
Other cash flow components:
Net cash provided by investing activities$29,941 $117,326 
Net cash used in financing activities$(56,527)$(25,824)
7

Three Months Ended June 30,
20242023
(unaudited)
(in thousands, except per share data and percentages)
GAAP cost of revenue$13,550 $13,153 
Adjusted to exclude the following:
Stock-based compensation(2,894)(2,461)
Amortization of acquired intangibles— (137)
Non-GAAP cost of revenue$10,656 $10,555 
GAAP gross profit$113,126 $95,316 
Adjusted to exclude the following:
Stock-based compensation2,894 2,461 
Amortization of acquired intangibles— 137 
Non-GAAP gross profit$116,020 $97,914 
GAAP gross margin89.3 %87.9 %
Non-GAAP gross margin91.6 %90.3 %
GAAP research and development expense$22,574 $21,931 
Adjusted to exclude the following:
Stock-based compensation(4,684)(3,256)
Non-GAAP research and development expense$17,890 $18,675 
GAAP sales and marketing expense$35,244 $34,455 
Adjusted to exclude the following:
Stock-based compensation(6,586)(5,995)
Amortization of acquired intangibles(1,061)(1,061)
Change in fair value of contingent earn-out consideration liability(202)(269)
Non-GAAP sales and marketing expense$27,395 $27,130 
GAAP general and administrative expense$9,255 $9,247 
Adjusted to exclude the following:
Stock-based compensation(2,926)(2,289)
Non-GAAP general and administrative expense$6,329 $6,958 
GAAP operating expense$67,073 $65,633 
Adjusted to exclude the following:
Stock-based compensation(14,196)(11,540)
Amortization of acquired intangibles(1,061)(1,061)
Change in fair value of contingent earn-out consideration liability(202)(269)
Non-GAAP operating expense$51,614 $52,763 
8

Three Months Ended June 30,
20242023
(unaudited)
(in thousands, except per share data and percentages)
GAAP operating income$46,053 $29,683 
Adjusted to exclude the following:
Stock-based compensation17,090 14,001 
Amortization of acquired intangibles1,061 1,198 
Change in fair value of contingent earn-out consideration liability202 269 
Non-GAAP operating income$64,406 $45,151 
GAAP net income$41,377 $28,406 
Adjusted to exclude the following:
Stock-based compensation17,090 14,001 
Amortization of acquired intangibles1,061 1,198 
Change in fair value of contingent earn-out consideration liability202 269 
Income tax effect of non-GAAP adjustments (1)
(3,854)(3,248)
Non-GAAP net income$55,876 $40,626 
Non-GAAP net income margin44.1 %37.5 %
Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:
Basic185,610 194,521 
Diluted199,224 212,355 
Non-GAAP net income per share attributable to Class A and Class B stockholders:
Basic$0.30 $0.21 
Diluted$0.28 $0.19 
(1) For the three months ended June 30, 2024 and 2023, management used an estimated annual effective non-GAAP tax rate of 21.0%.
9
v3.24.2.u1
Cover
Aug. 08, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Aug. 08, 2024
Entity Registrant Name Doximity, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-40508
Entity Tax Identification Number 27-2485512
Entity Address, Address Line One 500 3rd St.
Entity Address, Address Line Two Suite 510
Entity Address, City or Town San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94107
City Area Code 650
Local Phone Number 549-4330
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Class A common stock, $0.001 par value per share
Trading Symbol DOCS
Security Exchange Name NYSE
Entity Emerging Growth Company false
Entity Central Index Key 0001516513
Amendment Flag false
Document Information [Line Items]  
Document Period End Date Aug. 08, 2024
Doximity (NYSE:DOCS)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Doximity Charts.
Doximity (NYSE:DOCS)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Doximity Charts.